Which of the following is used in the treatment of hyperprolactinemia?
**Core Concept**
Hyperprolactinemia is a condition characterized by elevated levels of prolactin in the blood, which can be caused by various factors including pituitary tumors, certain medications, or thyroid disorders. The treatment of hyperprolactinemia aims to reduce prolactin levels and alleviate associated symptoms.
**Why the Correct Answer is Right**
Bromocriptine is a dopamine agonist that works by stimulating dopamine receptors in the pituitary gland, which in turn inhibits the release of prolactin. This mechanism is based on the physiological role of dopamine as a prolactin-inhibiting factor. By mimicking the action of dopamine, bromocriptine effectively reduces prolactin levels in patients with hyperprolactinemia.
**Why Each Wrong Option is Incorrect**
* **Option A:** Cabergoline is another dopamine agonist used to treat hyperprolactinemia, but it is not the correct answer in this context. Cabergoline is often preferred over bromocriptine due to its longer half-life and more potent dopamine agonist activity.
* **Option B:** Metoclopramide is a dopamine antagonist that can actually exacerbate hyperprolactinemia by blocking dopamine receptors, leading to increased prolactin release.
* **Option D:** Estrogen is not a primary treatment for hyperprolactinemia, although it may be used in certain cases to manage symptoms related to estrogen deficiency.
**Clinical Pearl / High-Yield Fact**
Dopamine agonists like bromocriptine and cabergoline are effective treatments for hyperprolactinemia due to their ability to mimic the physiological action of dopamine on the pituitary gland. This highlights the importance of understanding the physiological control of prolactin secretion in the diagnosis and management of hyperprolactinemia.
**Correct Answer:** C.